Efficacy of leukocyte- and platelet-rich fibrin in the treatment and prevention of medication-related osteonecrosis of the jaw: a prospective study
L-PRF represents a promising adjunct in MRONJ management, improving healing outcomes and postoperative recovery. Its autologous nature and growth factor release enhance bone regeneration, suggesting its potential as both a therapeutic and preventive strategy. Further larger-scale clinical trials are needed to standardize protocols and validate long-term efficacy.
Authors
- Mário Pérez‐Sayáns (ORCID: https://orcid.org/0000-0003-2196-9868)
- Pilar Gándara Vila (ORCID: https://orcid.org/0000-0003-2259-7971)
- Andrés Blanco Carrión (ORCID: https://orcid.org/0000-0002-7405-1834)
- Alba Pérez‐Jardón (ORCID: https://orcid.org/0000-0001-5174-8922)
- Alejandro I. Lorenzo‐Pouso (ORCID: https://orcid.org/0000-0002-9180-4703)
- G-C Camolesi
- A Medeiros-Monzón
Institutions
- Universidade de Santiago de Compostela (ES)
Publication Details
- Journal
- Medicina oral, patología oral y cirugía bucal
- Published
- 2025-01-01
- DOI
- https://doi.org/10.4317/medoral.27249
- Citations
- 3
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.14